BioPharma Resources

Drugs by condition

Drugs approved for heart failure

Brand-name prescription drugs and biologics whose FDA label lists heart failure as an approved use. Matched on the label phrases: "heart failure".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

94

Still marketed, NDA or BLA

Drug classes

16

Novel drugs

33

New molecular entities and new biologics

In development

35

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for heart failure.

  • Qlonilik (Clonidine Hydrochloride) · Cmp Dev LLC Jul 29, 2026
  • Javadin (Clonidine Hydrochloride) · Azurity Oct 23, 2025
  • Lasix Onyu (Furosemide) · Sq Innovation Oct 7, 2025
  • Enbumyst (Bumetanide) · Corstasis Therap Sep 12, 2025
  • Sdamlo (Amlodipine Besylate) · Brillian Pharma Jul 24, 2025

All approved drugs for heart failure, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 612 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Loop Diuretic (10)

Thiazide Diuretic (10)

  • Inzirqo Hydrochlorothiazide · Novitium Pharma · 2025
  • Tribenzor Amlodipine Besylate, Hydrochlorothiazide, Olmesartan Medoxomil · Cosette · 2010
  • Exforge Hct Amlodipine Besylate, Hydrochlorothiazide, Valsartan · Novartis · 2009
  • Benicar Hct Hydrochlorothiazide, Olmesartan Medoxomil · Cosette · 2003
  • Micardis Hct Hydrochlorothiazide, Telmisartan · Boehringer Ingelheim · 2000
  • Atacand Hct Candesartan Cilexetil, Hydrochlorothiazide · Ani Pharms · 2000
  • Diovan Hct Hydrochlorothiazide, Valsartan · Novartis · 1998
  • Avalide Hydrochlorothiazide, Irbesartan · Sanofi Aventis US · 1997
  • Hyzaar Hydrochlorothiazide, Losartan Potassium · Organon · 1995
  • Zestoretic Hydrochlorothiazide, Lisinopril · Almatica · 1989

Angiotensin 2 Receptor Blocker (6)

  • Entresto Sacubitril, Valsartan · Novartis Pharms Corp · 2015
  • Avapro Irbesartan · Sanofi Aventis US · 1997
  • Entresto Sprinkle Sacubitril, Valsartan · Novartis · 2024
  • Prexxartan Valsartan · Carmel Biosciences · 2017
  • Exforge Amlodipine Besylate, Valsartan · Novartis · 2007
  • Diovan Valsartan · Novartis · 2001

Sodium-Glucose Cotransporter 2 Inhibitor (4)

  • Inpefa Sotagliflozin · Lexicon Pharms INC · 2023
  • Jardiance Empagliflozin · Boehringer Ingelheim · 2014
  • Synjardy Xr Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
  • Synjardy Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2015

Aldosterone Antagonist (4)

  • Inspra Eplerenone · Upjohn · 2002
  • Aldactone Spironolactone · Pfizer · 1960
  • Carospir Spironolactone · Cmp Dev LLC · 2017
  • Aldactazide Hydrochlorothiazide, Spironolactone · Pfizer · 1961

Dihydropyridine Calcium Channel Blocker (2)

Thiazide-like Diuretic (2)

  • Edarbyclor Azilsartan Kamedoxomil, Chlorthalidone · Azurity · 2011
  • Thalitone Chlorthalidone · Casper Pharma LLC · 1988

Nitrate Vasodilator (2)

Cardiac Glycoside (2)

  • Digoxin Digoxin · Hikma · 2004
  • Lanoxin Digoxin · Advanz Pharma · 1997

Nonsteroidal Mineralocorticoid-Receptor Antagonist (1)

  • Kerendia Finerenone · Bayer Hlthcare · 2021

Soluble Guanylate Cyclase Stimulator (1)

Vasopressin V2 Receptor Antagonist (1)

  • Samsca Tolvaptan · Otsuka · 2009

alpha-Adrenergic Blocker (1)

  • Coreg Carvedilol · Waylis Therap · 1995

beta-Adrenergic Blocker (1)

Potassium-sparing Diuretic (1)

  • Dyrenium Triamterene · Advanz Pharma · 1964

Class not listed in FDA's data (46)

Drugs in development for heart failure

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • Maridebart cafraglutideAMG 133Phase 314 trials

    Amgen · Obesity, Overweight, Obstructive Sleep Apnea

  • HRS9531Phase 313 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Type 2 Diabetes, Chronic Management of Body Weight, Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  • NNC0487-0111Phase 312 trials

    Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • HRS-7535Phase 310 trials

    Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

  • ElecoglipronPhase 39 trials

    AstraZeneca · Type 2 Diabetes Mellitus, Obesity, Overweight

  • IBI362Phase 38 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Obesity, Overweight, Sleep Apnea

  • CM336group, QiShen YiQi Dripping Pills 3 bagsPhase 37 trials

    Keymed Biosciences Co.Ltd · Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia

  • HRS-1893Phase 35 trials

    Shandong Suncadia Medicine Co., Ltd. · Obstructive Hypertrophic Cardiomyopathy, Heart Failure With Preserved Ejection Fraction, Hypertrophic Cardiomyopathy

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • IRP101meta-fluorobenzylguanidine, 18F-MFBGPhase 34 trials

    Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy

  • ZiltivekimabPhase 34 trials

    Novo Nordisk · Acute Myocardial Infarction (AMI), Myocardial Infarction, Heart Failure

  • HiCM-188 therapyPhase 32 trials

    HELP Therapeutics Co., Ltd. · Heart Failure

  • Tasly Pharmaceutical Group Co., Ltd · Heart Failure, Chronic Heart Failure With Preserved Ejection Fraction

  • AtibuclimabIC14Phase 24 trials

    Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • AC01Phase 22 trials

    AnaCardio AB · Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Reduced Ejection Fraction

  • BimagrumabLY3985863, BYM338Phase 22 trials

    Eli Lilly · Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction

  • CDR132LPhase 22 trials

    Novo Nordisk · Heart Failure

  • CRD-4730Phase 22 trials

    Cardurion Pharmaceuticals, Inc. · Catecholaminergic Polymorphic Ventricular Tachycardia, Heart Failure With Reduced Ejection Fraction (HFrEF)

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

9 discontinued brand-name drugs whose label still names it

More on heart failure: recruiting trials · published research

Related in cardiovascular and metabolic: Type 2 diabetes · Type 1 diabetes · Obesity and weight management · High blood pressure (hypertension) · High cholesterol · High triglycerides · Atrial fibrillation · Blood clots (DVT and pulmonary embolism) · Stroke prevention · Coronary artery disease and heart attack

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.